Health product recalls and alerts, 2003
46 notices, newest first. Each links to the official notice.
Drugs, vaccines and biologics
- Archived – Update: Risk of Strangulation of Infants by IV Tubing and Monitor Leads – Notice to HospitalsDecember 29, 2003 · Health products · Product safety
- Archived - Hepatic Injury Associated with Beta-interferon Treatment for Multiple SclerosisDecember 11, 2003 · Biologic or vaccine
- Archived - The Dispensing of ClozapineNovember 21, 2003 · Drugs
- Archived - Product Recall Notice for Ventolin® Diskus® / Flovent® Diskus® / Serevent® Diskus® Inhalation DevicesNovember 18, 2003 · Drugs
- Archived - Recall of Ventolin® Diskus® / Serevent® Diskus® / Flovent® Diskus®November 14, 2003 · Drugs
- Archived – Product Recall Notice: Important Warning Regarding Diskus Inhalers – For the PublicNovember 14, 2003 · Drugs · New safety information
- Archived – Important New Safety Information Regarding ZENAPAX (Daclizumab)November 11, 2003 · Biologic or vaccine · New safety information
- Archived - Discontinuation Of Sales Of Nefazodone In CanadaNovember 3, 2003 · Drugs
- Archived - Discontinuation of Sales of Nefazodone in Canada: Letter to Pharmacists and WholesalersOctober 21, 2003 · Drugs
- Archived - Discontinuation of Sales of Nefazodone in CanadaOctober 21, 2003 · Drugs
- Archived - Important Safety Information Regarding Early Virologic Non-response in Patients with HIV Infection Treated with 3TC® (lamivudine), Ziagen® (abacavir) and VireadTM (tenofovir) - GlaxoSmithKline Inc.October 17, 2003 · Drugs
- Archived – Important Safety Information about ReFacto (Moroctocog alfa), Antihemophilic Factor (Recombinant) [BDDrFVIII]) – Wyeth CanadaSeptember 26, 2003 · Biologic or vaccine · Product safety
- Archived - Important Safety Information Regarding the Use of Effexor® (venlafaxine HCI) Tablets and Effexor® XR (venlafaxine HCI) Capsules in Children and Adolescents - Wyeth PharmaceuticalsSeptember 24, 2003 · Drugs
- Archived - Important Safety Information Regarding the Use of Effexor® (venlafaxine HCI) Tablets and Effexor® XR (venlafaxine HCI) Capsules in Children and Adolescents - Wyeth PharmaceuticalsSeptember 24, 2003 · Drugs
- Archived - Important Safety Information Regarding Serevent (salmeterol xinafoate) for Asthma - For the PublicSeptember 4, 2003 · Drugs
- Archived - Accelerated deaths using Casodex® (bicalutamide) 150 mg in patients with localized prostate cancerAugust 26, 2003 · Drugs
- Archived – Important Safety Information Regarding Casodex 150 mg – Accelerated Deaths in Localized Prostate Cancer Patients – For the PublicAugust 26, 2003 · Drugs · Product safety
- Archived - Important Medical Devices Safety Information - Product Correction and Removal On Your H-TRON V100 and H-TRONplus V100 Insulin Pump - For the PublicAugust 11, 2003 · Drugs
- Archived – Important Safety Information Regarding Estrogen Plus Progestin Tablets (PremplusTM) – For the PublicJuly 29, 2003 · Drugs · Product safety
- Archived - Public advisory - Important Safety Information Regarding Gluconorm (REPAGLINIDE) and Gemfibrozil and the Risk of Severe and Prolonged Hypoglycemia - For the PublicJuly 18, 2003 · Drugs
- Archived – Important Safety Information Regarding PAXIL® in Pediatric Patients – For the PublicJuly 18, 2003 · Drugs · Product safety
- Archived – Important Information – Topamax (topiramate) – Janssen Othro Inc.July 17, 2003 · Health products · Product safety
- Archived - Important Safety Information Regarding TOPAMAX: Decreased Sweating and Elevated Body Temperature - For the PublicJuly 17, 2003 · Drugs
- Archived - Important Drug Warning - Paxil® - Until further information is available, PAXIL® (paroxetine hydrochloride) should not be used in children and adolescents under 18 years of age - GlaxoSmithKlineJuly 10, 2003 · Health products
- Archived - Important Safety Information Regarding PERMAX® (pergolide mesylate) and Cardiac Valvulopathy - Eli Lilly Canada Inc. and Draxis Health Inc. - Health Professional AdvisoryApril 23, 2003 · Drugs
- Archived – Important Safety Information about the Risk of Heart Valve Problems for Patients Taking PERMAX® – For the PublicApril 23, 2003 · Drugs · Product safety
- Archived - Important Safety Information about DIANE®-35 and the risk of venous thromboembolism - Berlex Canada Inc. - Health Professional AdvisoryApril 10, 2003 · Drugs
- Archived - Diane® -35 and the Risk of Venous Thromboembolism - For the PublicApril 10, 2003 · Drugs
- Clarification of Dosing Recommendation for FRAGMIN® (dalteparin sodium injection) - Pharmacia Canada Inc. - Health Professional AdvisoryApril 1, 2003 · Drugs
- Archived - Advisory on Diethylstilbestrol (DES) and the Risk of Genital and Obstetrical Complications - Health Professional AdvisoryMarch 18, 2003 · Drugs
- Important information regarding Ethyol (amifostine) and severe cutaneous reactions - Health Professional AdvisoryMarch 12, 2003 · Drugs
- Archived – New Safety Information Associated with the Use of Zoloft in Patients Taking Pimozide – For the PublicMarch 5, 2003 · Drugs · New safety information
- Archived - Important Safety Information regarding ZOLOFT (sertaline hydrochloride) Pfizer Canada Inc. - Health Professional AdvisoryFebruary 28, 2003 · Drugs
- Archived - New contraindications for medications containing ergotamine and dihydroergotamine by Novartis Pharmaceuticals Canada Inc. - Consumer Information - For the PublicFebruary 18, 2003 · Drugs
- Archived - New CONTRAINDICATION regarding ergotamine- and dihydroergotamine-containing drugs: Risk of Cerebral and/or Peripheral Ischemia - Novartis Pharmaceuticals Canada IncJanuary 30, 2003 · Drugs
Medical devices
- Archived – Safety Warning Concerning the Use of Blue Food Dye in Enteral Feedings – Notice to HospitalsDecember 19, 2003 · Medical devices · Product safety
- Archived - Diskus Recall Return FormNovember 18, 2003 · Drugs - Medical devices
- Archived – Important Medical Devices Safety Information Regarding the Urgent Recall on Your Dahedi Insulin Pump – For the PublicNovember 10, 2003 · Medical devices · New safety information
- Archived – Urgent Product Recall on Dahedi Insulin PumpsNovember 6, 2003 · Medical devices · Medical devices
- Archived – Important Medical Devices Safety Information – Safety Alert on Your Panomat Infusion PumpNovember 6, 2003 · Medical devices · Product safety
- Archived - Important Medical Devices Safety Information - URGENT! Safety Alert On Your Panomat Infusion Pump - For the PublicNovember 6, 2003 · Medical devices
- Archived – Urgent Product Correction and Removal on Disetronic Infusion Pumps, D-Tronplus Insulin PumpAugust 11, 2003 · Medical devices · Product safety
- Archived – Disetronic H-TRON and H-TRONplus Insulin Pump – Disetronic Medical Systems, Inc.August 11, 2003 · Medical devices · Product safety
- Archived – Important Medical Devices Safety Information – Product Correction and Removal on Your D-TRONplus Insulin Pump - For the PublicAugust 11, 2003 · Medical devices · Medical devices
- Archived – Important Medical Devices Safety Information on CypherTM Coronary Stents and Subacute ThrombosisJuly 30, 2003 · Medical devices · Product safety
- Archived - Important safety Information Regarding Diathermy Therapy in Patients with Implanted Leads and Implanted Systems with LeadsApril 2, 2003 · Medical devices